RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Astrazeneca Pharma India - Stock

Astrazeneca Pharma India ROA 2024

Astrazeneca Pharma India ROA

0

Ticker

ASTRAZEN.NS

ISIN

INE203A01020

In 2024, Astrazeneca Pharma India's return on assets (ROA) was 0, a -100% increase from the 0.07 ROA in the previous year.

Astrazeneca Pharma India Aktienanalyse

What does Astrazeneca Pharma India do?

Astrazeneca Pharma India ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Astrazeneca Pharma India's Return on Assets (ROA)

Astrazeneca Pharma India's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Astrazeneca Pharma India's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Astrazeneca Pharma India's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Astrazeneca Pharma India’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Astrazeneca Pharma India Stock

What is the Return on Assets (ROA) of Astrazeneca Pharma India this year?

The Return on Assets (ROA) of Astrazeneca Pharma India is 0 undefined this year.

What was the ROA of Astrazeneca Pharma India compared to the previous year?

The ROA of Astrazeneca Pharma India has increased by -100% compared to the previous year.

What consequences do high ROA have for investors of Astrazeneca Pharma India?

A high ROA is advantageous for investors of Astrazeneca Pharma India, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Astrazeneca Pharma India?

A low ROA can be unfavorable for investors of Astrazeneca Pharma India as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Astrazeneca Pharma India affect the company?

An increase in ROA of Astrazeneca Pharma India can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Astrazeneca Pharma India impact the company?

A reduction in the ROA of Astrazeneca Pharma India can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Astrazeneca Pharma India?

Some factors that can influence the ROA of Astrazeneca Pharma India include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Astrazeneca Pharma India important for investors?

The ROA of Astrazeneca Pharma India is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Astrazeneca Pharma India take to improve ROA?

To improve ROA, Astrazeneca Pharma India can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Astrazeneca Pharma India pay?

Over the past 12 months, Astrazeneca Pharma India paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Astrazeneca Pharma India is expected to pay a dividend of 16 INR.

What is the dividend yield of Astrazeneca Pharma India?

The current dividend yield of Astrazeneca Pharma India is .

When does Astrazeneca Pharma India pay dividends?

Astrazeneca Pharma India pays a quarterly dividend. This is distributed in the months of September, September, August, August.

How secure is the dividend of Astrazeneca Pharma India?

Astrazeneca Pharma India paid dividends every year for the past 0 years.

What is the dividend of Astrazeneca Pharma India?

For the upcoming 12 months, dividends amounting to 16 INR are expected. This corresponds to a dividend yield of 0.26 %.

In which sector is Astrazeneca Pharma India located?

Astrazeneca Pharma India is assigned to the 'Health' sector.

Wann musste ich die Aktien von Astrazeneca Pharma India kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Astrazeneca Pharma India from 9/13/2023 amounting to 16 INR, you needed to have the stock in your portfolio before the ex-date on 7/14/2023.

When did Astrazeneca Pharma India pay the last dividend?

The last dividend was paid out on 9/13/2023.

What was the dividend of Astrazeneca Pharma India in the year 2023?

In the year 2023, Astrazeneca Pharma India distributed 8 INR as dividends.

In which currency does Astrazeneca Pharma India pay out the dividend?

The dividends of Astrazeneca Pharma India are distributed in INR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Astrazeneca Pharma India

Our stock analysis for Astrazeneca Pharma India Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Astrazeneca Pharma India Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.